ANGO Logo

AngioDynamics, Inc. (ANGO) 

NASDAQ
Market Cap
$290.13M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
188 of 776
Rank in Industry
13 of 48

Largest Insider Buys in Sector

ANGO Stock Price History Chart

ANGO Stock Performance

About AngioDynamics, Inc.

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract …

Insider Activity of AngioDynamics, Inc.

Over the last 12 months, insiders at AngioDynamics, Inc. have bought $202,847 and sold $0 worth of AngioDynamics, Inc. stock.

On average, over the past 5 years, insiders at AngioDynamics, Inc. have bought $516,566 and sold $770,544 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Clemmer James C (President and CEO) — $187,600. Nighan Warren JR (SVP Quality and Regulatory) — $10,570. Trowbridge Stephen A (EVP and CFO) — $9,962.

The last purchase of 100 shares for transaction amount of $608 was made by Nighan Warren JR (SVP Quality and Regulatory) on 2024‑10‑10.

List of Insider Buy and Sell Transactions, AngioDynamics, Inc.

2024-10-10PurchaseSVP Quality and Regulatory
100
0.0002%
$6.08$608+6.51%
2024-10-08PurchaseEVP and CFO
1,700
0.0033%
$5.86$9,962+9.69%
2024-10-07PurchasePresident and CEO
20,000
0.0399%
$6.03$120,600+5.33%
2024-10-07PurchaseSVP Quality and Regulatory
768
0.0015%
$6.09$4,677+5.33%
2024-04-08PurchasePresident and CEO
10,000
0.0254%
$6.70$67,000-2.87%
2023-01-31SaleSVP Global Operations and R&D
4,633
0.0117%
$12.95$59,997-34.41%
2022-10-12PurchaseEVP and CFO
1,083
0.0027%
$13.82$14,967-23.49%
2022-10-10PurchasePresident and CEO
10,000
0.0264%
$15.00$150,000-24.76%
2022-07-29SaleSVP Global Operations and R&D
5,000
0.0126%
$22.44$112,200-43.32%
2022-04-28SaleSVP Global Operations and R&D
3,513
0.009%
$22.44$78,832-37.25%
2022-04-12Saledirector
1,299
0.0034%
$23.26$30,215-34.97%
2022-04-11Sale
7,500
0.0197%
$23.05$172,838-31.92%
2022-01-12PurchaseEVP and CFO
2,000
0.0052%
$22.64$45,280-6.16%
2022-01-11PurchasePresident and CEO
20,000
0.0498%
$22.84$456,800-11.60%
2021-10-20SaleSVP Global Operations and R&D
6,988
0.0176%
$27.97$195,454-21.70%
2021-10-15SaleSr. VP/GM, Global VIT
24,000
0.0627%
$27.92$670,080-18.23%
2021-10-05SaleSVP/GM, Vascular Access
21,496
0.0543%
$27.15$583,616-17.96%
2021-04-14SaleSVP Global Operations and R&D
7,000
0.0182%
$23.93$167,510+6.62%
2021-01-20Saledirector
13,000
0.0335%
$18.53$240,890+35.77%
2020-08-11PurchaseEVP and CFO
2,026
0.0055%
$9.38$19,004+123.55%

Insider Historical Profitability

10.06%
Clemmer James CPresident and CEO
681582
1.6774%
$7.1480+14.85%
Trowbridge Stephen AEVP and CFO
172711
0.425%
$7.1442+31.3%
Nighan Warren JRSVP Quality and Regulatory
45877
0.1129%
$7.1420
HOBBS EAMONN PPresident & CEO
100401
0.2471%
$7.14327+11.48%
BUCCI VINCENTdirector
86696
0.2134%
$7.1490<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$27.49M11.694.68M-7.17%-$2.12M<0.01
The Vanguard Group$13.11M5.582.23M-1.57%-$209,007.24<0.0001
Systematic Financial Management LLC$11.43M4.861.95M+0.75%+$84,733.460.32
Morgan Stanley$11.02M4.681.88M-0.51%-$56,070.26<0.01
Dimensional Fund Advisors$7.96M3.381.36M-8.98%-$784,936.44<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.